[1]
|
Critchley, M. (1931) The Neurology of Old Age. The Lancet, 1, 1221-1230.
https://doi.org/10.1016/S0140-6736(00)90761-X
|
[2]
|
Forbes, G.B. and Halloran, E. (1976) The Adult Decline in Lean Body Mass. Human Biology, 48, 161-173.
|
[3]
|
Rosenberg, I.H. (1997) Sarcopenia: Origins and Clinical Rele-vance. The Journal of Nutrition, 127, 990s-991s.
https://doi.org/10.1093/jn/127.5.990S
|
[4]
|
Cruz-Jentoft, A.J., Baeyens, J.P., Bauer, J.M., Boirie, Y., Cederholm, T., Landi, F., Martin, F.C., et al. (2010) Sarcopenia: European Consensus on Definition and Diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing, 39, 412-423. https://doi.org/10.1093/ageing/afq034
|
[5]
|
Chen, L.-K., Liu, L.-K., Woo, J., Assantachai, P., Auyeung, T.-W., Bahyah, K.S., et al. (2014) Sarcopenia in Asia: Consensus Report of the Asian Working Group for Sarcopenia. Journal of the American Medical Directors Association, 15, 95-101. https://doi.org/10.1016/j.jamda.2013.11.025
|
[6]
|
Sillanpaa, E., Cheng, S., Hakkinen, K., Finni, T., Walker, S., Pe-sola, A., et al. (2014) Body Composition in 18- to 88-Year-Old Adults—Comparison of Multifrequency Bioimpedance and Dual-Energy X-Ray Absorptiometry. Obesity (Silver Spring), 22, 101-109. https://doi.org/10.1002/oby.20583
|
[7]
|
Chen, L.-K., Woo, J., Assantachai, P., Auyeung, T.-W., Chou, M.-Y., Iiji-ma, K., et al. (2020) Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment. Journal of the American Medical Directors Association, 21, 300-307.e2. https://doi.org/10.1016/j.jamda.2019.12.012
|
[8]
|
Malmstrom, T.K. and Morley, J.E. (2013) SARC-F: A Simple Questionnaire to Rapidly Diagnose Sarcopenia. Journal of the American Medical Directors Association, 14, 531-532. https://doi.org/10.1016/j.jamda.2013.05.018
|
[9]
|
Ishii, S., Tanaka, T., Shibasaki, K., Ouchi, Y., Kikutani, T., Hi-gashiguchi, T., et al. (2014) Development of a Simple Screening Test for Sarcopenia in Older Adults. Geriatrics & Ger-ontology International, 14, 93-101.
https://doi.org/10.1111/ggi.12197
|
[10]
|
Barbosa-Silva, T.G., Menezes, A.M.B., Bielemann, R.M., Malmstrom, T.K. and Gonzalez, M.C. (2016) Enhancing SARC-F: Improving Sarcopenia Screening in the Clinical Practice. Journal of the American Medical Directors Association, 17, 1136-1141. https://doi.org/10.1016/j.jamda.2016.08.004
|
[11]
|
Tanaka, T., Takahashi, K., Akishita, M., Tsuji, T. and Iijima, K. (2018) “Yubi-Wakka” (Finger-Ring) Test: A Practical Self-Screening Method for Sarcopenia, and a Predictor of Disability and Mortality among Japanese Community-Dwelling Older Adults. Geriatrics & Gerontology International, 18, 224-232. https://doi.org/10.1111/ggi.13163
|
[12]
|
Rossi, A.P., Micciolo, R., Rubele, S., Fantin, F., Caliari, C., Zoico, E., et al. (2017) Assessing the Risk of Sarcopenia in the El-derly: The Mini Sarcopenia Risk Assessment (MSRA) Questionnaire. The Journal of Nutrition, Health Aging, 21, 743-749. https://doi.org/10.1007/s12603-017-0921-4
|
[13]
|
O’Sullivan, D., O’Regan, N.A. and Timmons, S. (2016) Validity and Reliability of the 6-Item Cognitive Impairment Test for Screening Cognitive Impairment: A Review. Demen-tia and Geriatric Cognitive Disorders, 42, 42-49.
https://doi.org/10.1159/000448241
|
[14]
|
Curcio, F., Ferro, G., Basile, C., Liguori, I., Parrella, P., Pirozzi, F., et al. (2016) Biomarkers in Sarcopenia: A Multifactorial Approach. Experimental Gerontology, 85, 1-8. https://doi.org/10.1016/j.exger.2016.09.007
|
[15]
|
Clark, R.V., Walker, A.C., O’Connor-Semmes, R.L., Leonard, M.S., Miller, R.R., Stimpson, S.A., et al. (2014) Total Body Skeletal Muscle Mass: Estimation by Creatine (methyl-d3) Dilution in Humans. Journal of Applied Physiology (1985), 116, 1605-1613. https://doi.org/10.1152/japplphysiol.00045.2014
|
[16]
|
Casati, M., Costa, A.S., Capitanio, D., Ponzoni, L., Ferri, E., Agostini, S. and Lori, E. (2019) The Biological Foundations of Sarcopenia: Established and Promising Markers. Fron-tiers in Medicine (Lausanne), 6, Article No. 184.
https://doi.org/10.3389/fmed.2019.00184
|
[17]
|
Monti, E., Sarto, F., Sartori, R., Zanchettin, G., Lofler, S., Kern, H., Narici, M.V. and Zampieri, S. (2023) C-Terminal Agrin Fragment as a Biomarker of Muscle Wasting and Weakness: A Narrative Review. Journal of Cachexia, Sarcopenia and Muscle, 14, 730-744. https://doi.org/10.1002/jcsm.13189
|
[18]
|
Baczek, J., Silkiewicz, M. and Wojszel, Z.B. (2020) Myostatin as a Bi-omarker of Muscle Wasting and Other Pathologies-State of the Art and Knowledge Gaps. Nutrients, 12, Article No. 2401. https://doi.org/10.3390/nu12082401
|
[19]
|
De Paepe, B. (2022) The Cytokine Growth Differentiation Factor-15 and Skeletal Muscle Health: Portrait of an Emerging Widely Applicable Disease Biomarker. International Journal of Molec-ular Sciences, 23, Article No. 13180.
https://doi.org/10.3390/ijms232113180
|
[20]
|
Du, Y., Xu, C., Shi, H., Jiang, X., Tang, W., Wu, X., et al. (2021) Serum Concentrations of Oxytocin, DHEA and Follistatin Are Associated with Osteoporosis or Sarcopenia In commu-nity-Dwelling Postmenopausal Women. BMC Geriatrics, 21, Article No. 542. https://doi.org/10.1186/s12877-021-02481-7
|
[21]
|
Chang, J.S., Kim, T.H., Nguyen, T.T., Park, K.S., Kim, N. and Kong, I.D. (2017) Circulating Irisin Levels as a Predictive Biomarker for Sarcopenia: A Cross-Sectional Communi-ty-Based Study. Geriatrics & Gerontology International, 17, 2266-2273. https://doi.org/10.1111/ggi.13030
|
[22]
|
Paris, M.T., Bell, K.E. and Mourtzakis, M. (2020) Myokines and Adi-pokines in Sarcopenia: Understanding Cross-Talk between Skeletal Muscle and Adipose Tissue and the Role of Exercise. Current Opinion in Pharmacology, 52, 61-66.
https://doi.org/10.1016/j.coph.2020.06.003
|
[23]
|
Walowski, C.O., Herpich, C., Enderle, J., Braun, W., Both, M., Hasler, M., et al. (2023) Analysis of the Adiponectin Paradox in Healthy Older People. Journal of Cachexia, Sarcopenia and Muscle, 14, 270-278.
https://doi.org/10.1002/jcsm.13127
|
[24]
|
Schweighofer, N., Haudum, C.W., Trummer, O., Lind, A., Kolesnik, E., Mursic, I., et al. (2022) Dp-ucMGP as a Biomarker in Sarcopenia. Nutrients, 14, Article No. 5400. https://doi.org/10.3390/nu14245400
|
[25]
|
Lin, W.J., Lee, W.J., Peng, L.N., Huang, Y.L., Tung, C.Y., Lin, C.H., Tsai, T.F. and Chen, L.K. (2023) Anti-Tumor Necrosis Factor-Alpha Is Potentially Better than Tumor Necrosis Factor-Alpha as the Biomarker for Sarcopenia: Results from the I-Lan Longitudinal Aging Study. Experimental Geron-tology, 172, Article ID: 112053.
https://doi.org/10.1016/j.exger.2022.112053
|
[26]
|
Habib, S.S., Alkahtani, S., Alhussain, M. and Aljuhani, O. (2020) Sarcopenia Coexisting with High Adiposity Exacerbates Insulin Resistance and Dyslipidemia in Saudi Adult Men. Dia-betes, Metabolic Syndrome and Obesity, 13, 3089-3097.
https://doi.org/10.2147/DMSO.S260382
|
[27]
|
Silva-Fhon, J.R., Rojas-Huayta, V.M., Aparco-Balboa, J.P., Cespedes-Panduro, B. and Partezani-Rodrigues, R.A. (2021) Sarcopenia and Blood Albumin: A Systematic Review with Meta-Analysis. Biomedica, 41, 590-603.
https://doi.org/10.7705/biomedica.5765
|
[28]
|
Tseng, S.H., Lee, W.J., Peng, L.N., Lin, M.H. and Chen, L.K. (2021) Associations between Hemoglobin Levels and Sarcopenia and Its Components: Results from the I-Lan Longitudinal Study. Experimental Gerontology, 150, Article ID: 111379. https://doi.org/10.1016/j.exger.2021.111379
|
[29]
|
Nakajima, H., Okada, H., Kobayashi, A., Takahashi, F., Okamura, T., Hashimoto, Y., et al. (2023) Leucine and Glutamic Acid as a Biomarker of Sarcopenic Risk in Japanese People with Type 2 Diabetes. Nutrients, 15, Article No. 2400.
https://doi.org/10.3390/nu15102400
|
[30]
|
Osawa, Y., Candia, J., Abe, Y., Tajima, T., Oguma, Y. and Arai, Y. (2023) Plasma Amino Acid Signature for Sarcopenic Phenotypes in Community-Dwelling Octogenarians: Results from the Kawasaki Aging Wellbeing Project. Experimental Gerontology, 178, Article ID: 112230. https://doi.org/10.1016/j.exger.2023.112230
|
[31]
|
Sanayama, H., Ito, K., Ookawara, S., Uemura, T., Sakiyama, Y., Sugawara, H., et al. (2023) Whole Blood Spermine/Spermidine Ratio as a New Indicator of Sarcopenia Status in Older Adults. Biomedicines, 11, Article No. 1403.
https://doi.org/10.3390/biomedicines11051403
|
[32]
|
Hata, R., Miyamoto, K., Abe, Y., Sasaki, T., Oguma, Y., Ta-jima, T., et al. (2023) Osteoporosis and Sarcopenia Are Associated with Each Other and Reduced IGF1 Levels Are a Risk for both Diseases in the Very Old Elderly. Bone, 166, Article ID: 116570. https://doi.org/10.1016/j.bone.2022.116570
|
[33]
|
Ghafouri-Fard, S., Askari, A., Mahmud Hussen, B., Taheri, M. and Kiani, A. (2023) Sarcopenia and Noncoding RNAs: A Comprehensive Review. Journal of Cellular Physiology, 238, 1416-1430. https://doi.org/10.1002/jcp.31031
|
[34]
|
Furutani, M., Suganuma, M., Akiyama, S., Mitsumori, R., Takemura, M., Matsui, Y., et al. (2023) RNA-Sequencing Analysis Identification of Potential Biomarkers for Diagnosis of Sarcopenia. Journals of Gerontology—Series A Biological Sciences and Medical Sciences, glad150. https://doi.org/10.1093/gerona/glad150
|
[35]
|
Lin, S., Ling, M., Chen, C., Cai, X., Yang, F. and Fan, Y. (2022) Screening Potential Diagnostic Biomarkers for Age-Related Sarcopenia in the Elderly Population by WGCNA and LASSO. BioMed Research International, 2022, Article ID: 7483911. https://doi.org/10.1155/2022/7483911
|
[36]
|
Wu, J., Cao, L., Wang, J., Wang, Y., Hao, H. and Huang, L. (2022) Characterization of Serum Protein Expression Profiles in the Early Sarcopenia Older Adults with Low Grip Strength: A Cross-Sectional Study. BMC Musculoskeletal Disorders, 23, Article No. 894. https://doi.org/10.1186/s12891-022-05844-2
|
[37]
|
D’Amico, F., Barone, M., Brigidi, P. and Turroni, S. (2023) Gut Microbiota in Relation to Frailty and Clinical Outcomes. Current Opinion in Clinical Nutrition & Metabolic Care, 26, 219-225.
https://doi.org/10.1097/MCO.0000000000000926
|
[38]
|
Kwak, J.Y., Hwang, H., Kim, S.K., Choi, J.Y., Lee, S.M., Bang, H., et al. (2018) Prediction of Sarcopenia Using a Combination of Multiple Serum Biomarkers. Scientific Reports, 8, Article No. 8574.
https://doi.org/10.1038/s41598-018-26617-9
|